Quest Diagnostics Incorporated

Quest Diagnostics Incorporated

DGX · NYSE · Healthcare / Diagnostics & Research

259.60USD-0.05 (-0.02%)

Price History

Full chart

Market Stats

Previous Close259.65
Open260.17
Day Range258.56 – 260.91
52-Week Range168.34 – 247.92
Volume649.29K
Market Cap26.70B
P/E (TTM)24.09
Forward P/E19.53
EPS10.04
Dividend Yield1.42%
Beta0.54
50-Day Avg237.60
200-Day Avg210.44

About

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; healthcare IT healthcare providers and payers; testing and medical director services at hospital laboratories; test offerings in cardiometabolic and endocrine; cancer; clinical drug monitoring and toxicology; infectious disease, including autoimmune; neurology diagnostics, including Alzheimer's disease; and women's health, such as prenatal genetic; workplace drug testing, testing urine, hair, and oral fluid specimens services; and employer population health services, including biometric screenings, flu shots, and related preventative services. Further, it provides population health solutions; extended care services; develops in vitro diagnostic tests; laboratory diagnostic information and digital health connectivity systems; underwriting support services, including data gathering, paramedical examinations, and clinical laboratory testing and analytics; and national specimen collection and health data solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Company Details

  • SectorHealthcare
  • IndustryDiagnostics & Research
  • CEOMr. James E. Davis
  • Employees60.00K
  • Headquarters500 Plaza Drive, Secaucus, NJ, United States, 07094, USA
  • Websitehttps://www.questdiagnostics.com

Leadership

  • Mr. James E. DavisChairman, CEO & President · b. 1963
  • Mr. Sam A. SamadExecutive VP & CFO · b. 1970
  • Mr. Michael E. Prevoznik J.D.Senior VP & General Counsel · b. 1962
  • Ms. Catherine T. DohertyExecutive Vice President of Regional Businesses · b. 1963
  • Mr. Karthik Kuppusamy Ph.D.Senior Vice President of Clinical Solutions · b. 1970
  • Mr. Michael J. DeppeSenior VP, Corporate Controller & Chief Accounting Officer · b. 1967
  • Mr. Murali BalakumarSenior VP and Chief Information & Digital Officer
  • Ms. Damini ChokshiVice President of Investor Relations
  • Ms. Kristin Lee Wallace Esq.Senior VP & Chief Compliance Officer
  • Mr. Garry ClarkSenior VP and Chief Marketing & Communications Officer

Financials

Income Statement

Currency: USD1996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.62B1.53B1.46B2.21B3.42B3.63B4.11B4.74B5.13B5.50B6.27B6.70B7.25B7.46B7.37B7.51B7.38B7.15B7.43B7.49B7.51B7.71B7.53B7.73B9.44B10.79B9.88B9.25B9.87B11.04B
Growth (%)--5.42%-4.59%+51.19%+55.14%+6.04%+13.24%+15.33%+8.20%+7.36%+13.90%+6.96%+8.12%+2.84%-1.16%+1.92%-1.70%-3.20%+4.04%+0.78%+0.29%+2.58%-2.31%+2.59%+22.15%+14.32%-8.39%-6.38%+6.70%+11.78%
Cost of Revenue1.01B875.50M813.90M1.32B1.97B2.15B2.43B2.77B2.99B3.26B3.70B3.97B4.26B4.32B4.32B4.40B4.36B4.33B4.64B4.66B4.62B4.72B4.93B5.04B5.80B6.58B6.45B6.20B6.63B7.51B
Gross Profit605.42M653.20M644.70M886.20M1.45B1.48B1.68B1.97B2.14B2.25B2.57B2.74B2.99B3.13B3.05B3.12B3.02B2.82B2.80B2.84B2.90B2.99B2.60B2.69B3.63B4.21B3.43B3.05B3.24B3.52B
Gross Margin37.46%42.73%44.20%40.19%42.49%40.69%40.79%41.57%41.66%40.82%41.04%40.79%41.29%42.03%41.41%41.48%40.88%39.46%37.63%37.85%38.58%38.79%34.59%34.80%38.50%39.02%34.74%33.00%32.86%31.93%
Operating Expense1.21B578.50M550.40M734.20M1.14B1.06B1.08B1.17B1.23B1.28B1.44B1.64B1.77B1.77B1.76B2.12B1.82B1.34B1.81B1.44B1.62B1.82B1.50B1.46B1.66B1.83B2.00B1.79B1.90B1.92B
Operating Income-601.28M74.70M94.30M152.00M317.82M411.39M592.45M795.43M901.44M968.11M1.13B1.09B1.22B1.36B1.30B995.00M1.20B1.48B983.00M1.40B1.28B1.17B1.10B1.23B1.97B2.38B1.43B1.26B1.35B1.60B
Operating Margin-37.20%4.89%6.47%6.89%9.29%11.34%14.42%16.79%17.58%17.59%17.99%16.28%16.86%18.23%17.58%13.25%16.27%20.64%13.22%18.67%16.99%15.11%14.62%15.93%20.89%22.07%14.45%13.64%13.63%14.53%
EBITDA-502.19M151.10M163.10M242.80M452.11M559.12M723.84M950.36M1.05B1.18B1.33B1.33B1.50B1.63B1.59B1.30B1.52B1.79B1.30B1.55B1.48B1.45B1.40B1.58B2.41B3.16B1.82B1.26B1.89B2.19B
EBITDA Margin-31.07%9.88%11.18%11.01%13.22%15.41%17.62%20.06%20.47%21.51%21.14%19.82%20.70%21.88%21.52%17.34%20.63%25.09%17.54%20.75%19.68%18.85%18.64%20.52%25.55%29.28%18.42%13.64%19.19%19.88%
Net Income-625.96M-22.30M26.90M-3.40M102.05M162.30M322.15M436.72M499.19M546.28M586.42M339.94M581.50M729.10M720.90M470.60M555.70M849.00M556.00M709.00M645.00M772.00M736.00M858.00M1.43B2.00B946.00M854.00M871.00M992.00M
Net Income Margin-38.73%-1.46%1.84%-0.15%2.98%4.47%7.84%9.22%9.74%9.93%9.35%5.07%8.02%9.78%9.78%6.27%7.53%11.88%7.48%9.46%8.58%10.01%9.77%11.11%15.16%18.49%9.57%9.23%8.82%8.99%
R&D-------------0000000000-------
R&D as % of Total Revenue-------------0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-------
Interest Expense000000000000185.48M144.10M146.10M170.60M168.00M162.00M167.00M153.00M143.00M153.00M169.00M180.00M166.00M152.00M148.00M152.00M226.00M277.00M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%2.56%1.93%1.98%2.27%2.28%2.27%2.25%2.04%1.90%1.98%2.24%2.33%1.76%1.41%1.50%1.64%2.29%2.51%

Balance Sheet

Currency: USD1996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.40B1.40B1.36B2.88B2.86B2.93B3.32B4.30B4.20B5.31B5.66B8.57B8.40B8.56B8.53B9.31B9.28B8.95B9.88B9.96B10.10B10.50B11.00B12.84B14.03B13.61B12.84B14.02B16.15B16.23B
Total Liabilities856.35M859.20M792.30M2.02B1.83B1.59B1.56B1.91B1.92B2.54B2.64B5.24B4.80B4.55B4.47B5.60B5.10B4.97B5.55B5.18B5.36B5.47B5.66B7.08B7.13B7.05B6.83B7.60B9.26B8.94B
Total Equity538.72M541.70M567.90M863.10M1.03B1.34B1.77B2.39B2.29B2.76B3.02B3.32B3.60B3.99B4.03B3.71B4.16B3.95B4.30B4.68B4.63B4.92B5.22B5.64B6.76B6.44B5.89B6.31B6.78B7.17B
Cash41.96M161.70M202.90M27.30M171.48M122.33M96.78M154.96M73.30M92.13M149.64M167.59M253.90M534.30M449.30M164.90M295.60M187.00M192.00M133.00M359.00M137.00M135.00M1.19B1.16B872.00M315.00M686.00M549.00M420.00M
Total Debt535.79M514.80M464.80M1.22B1.03B821.74M822.54M1.10B1.10B1.59B1.56B3.54B3.08B3.11B2.99B4.02B3.36B3.33B3.76B3.65B3.73B3.85B3.99B5.42B4.81B4.77B4.71B5.50B7.09B6.92B
Net Debt493.83M353.10M261.90M1.19B854.64M699.41M725.76M947.70M1.03B1.50B1.41B3.37B2.83B2.57B2.54B3.86B3.07B3.15B3.57B3.52B3.38B3.72B3.86B4.22B3.65B3.90B4.40B4.81B6.54B6.50B

Cash Flow

Currency: USD1996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-88.49M176.30M141.40M249.50M369.45M465.80M596.37M662.80M798.78M851.58M951.90M926.92M1.06B997.40M1.12B895.50M1.19B652.00M938.00M810.00M1.07B1.18B1.20B1.24B2.00B2.23B1.72B1.27B1.33B1.89B
Investing Cash Flow-63.67M-35.10M-39.70M-1.11B-48.02M-296.62M-477.21M-417.05M-173.70M-1.08B-414.40M-1.76B-198.90M-195.90M-216.50M-1.24B-217.10M328.00M-1.02B-362.00M-152.00M-805.00M-801.00M-411.00M-772.00M21.00M-543.00M-1.06B-2.55B-631.00M
Financing Cash Flow157.67M-21.50M-60.40M682.80M-177.25M-218.33M-144.71M-187.57M-706.74M247.04M-479.98M850.22M-777.90M-521.10M-986.50M63.50M-822.10M-1.11B92.00M-507.00M-691.00M-592.00M-401.00M225.00M-1.27B-2.54B-1.73B160.00M1.08B-1.39B
Capital Expenditure70.40M46.80M40.50M1.10B116.45M148.99M155.20M174.64M176.13M224.27M193.42M219.10M212.70M166.90M205.40M161.50M182.20M231.00M308.00M263.00M293.00M252.00M383.00M400.00M418.00M403.00M404.00M408.00M425.00M527.00M
Free Cash Flow-158.88M129.50M100.90M-851.50M253.00M316.82M441.18M488.16M622.65M627.31M758.47M707.82M850.40M830.50M912.60M734.00M1.00B421.00M630.00M547.00M776.00M923.00M817.00M843.00M1.59B1.83B1.31B864.00M909.00M1.36B
Dividends Paid1.17M100.00K100.00K100.00K6.90M8.95M--61.39M69.67M77.14M77.33M78.00M110.20M108.00M64.70M108.10M185.00M187.00M212.00M223.00M247.00M266.00M286.00M297.00M309.00M305.00M314.00M331.00M353.00M
FCF to OCF179.56%73.45%71.36%-341.28%68.48%68.02%73.98%73.65%77.95%73.66%79.68%76.36%79.99%83.27%81.63%81.97%84.65%64.57%67.16%67.53%72.59%78.55%68.08%67.82%79.15%81.95%76.48%67.92%68.14%72.06%
Dividend Paid to FCF-0.74%0.08%0.10%-0.01%2.73%2.83%--9.86%11.11%10.17%10.92%9.17%13.27%11.83%8.81%10.76%43.94%29.68%38.76%28.74%26.76%32.56%33.93%18.71%16.89%23.21%36.34%36.41%25.97%

Earnings

Report DateJan 27, 1997Apr 16, 1997Jul 16, 1997Oct 20, 1997Jan 27, 1998Apr 14, 1998Jul 15, 1998Oct 14, 1998Jan 27, 1999Apr 14, 1999Jul 16, 1999Oct 26, 1999Jan 27, 2000Apr 24, 2000Jul 24, 2000Oct 19, 2000Jan 29, 2001Apr 23, 2001Jul 23, 2001Oct 18, 2001Jan 28, 2002Apr 18, 2002Jul 22, 2002Oct 17, 2002Jan 23, 2003Apr 22, 2003Jul 22, 2003Oct 21, 2003Jan 27, 2004Apr 22, 2004Jul 22, 2004Oct 25, 2004Jan 27, 2005Apr 21, 2005Jul 25, 2005Oct 20, 2005Jan 26, 2006Apr 20, 2006Jul 24, 2006Oct 19, 2006Jan 25, 2007Apr 19, 2007Jul 24, 2007Oct 24, 2007Feb 21, 2008Apr 21, 2008Jul 22, 2008Oct 21, 2008Jan 26, 2009Apr 21, 2009Jul 21, 2009Oct 20, 2009Jan 25, 2010Apr 21, 2010Jul 21, 2010Oct 20, 2010Jan 25, 2011Apr 20, 2011Jul 20, 2011Oct 25, 2011Jan 24, 2012Apr 18, 2012Jul 19, 2012Oct 17, 2012Jan 23, 2013Apr 17, 2013Jul 18, 2013Oct 17, 2013Jan 30, 2014Apr 24, 2014Jul 24, 2014Oct 23, 2014Jan 29, 2015Apr 23, 2015Jul 23, 2015Oct 22, 2015Jan 28, 2016Apr 21, 2016Jul 21, 2016Oct 20, 2016Jan 26, 2017Apr 20, 2017Jul 25, 2017Oct 19, 2017Feb 1, 2018Apr 19, 2018Jul 24, 2018Oct 23, 2018Feb 14, 2019Apr 23, 2019Jul 23, 2019Oct 22, 2019Jan 30, 2020Apr 22, 2020Jul 23, 2020Oct 22, 2020Feb 4, 2021Apr 22, 2021Jul 22, 2021Oct 21, 2021Feb 3, 2022Apr 21, 2022Jul 21, 2022Oct 20, 2022Feb 2, 2023Apr 27, 2023Jul 26, 2023Oct 24, 2023Feb 1, 2024Apr 23, 2024Jul 23, 2024Oct 22, 2024Jan 30, 2025Apr 22, 2025Jul 22, 2025Oct 21, 2025Feb 10, 2026Apr 21, 2026Jul 23, 2026Oct 22, 2026
EPS Estimate-0.010.020.060.030.010.030.070.050.040.060.080.070.050.090.160.120.150.160.240.240.240.300.420.420.390.410.550.540.490.530.640.630.610.630.720.710.620.650.760.760.740.690.680.760.780.700.780.820.800.820.960.970.960.981.061.000.910.991.121.111.061.011.171.181.061.041.091.020.930.891.061.081.051.041.231.261.191.121.321.351.271.181.421.361.371.501.761.681.371.381.681.711.600.881.253.734.243.732.863.063.213.002.272.191.901.972.262.192.111.862.332.262.182.152.572.502.362.372.812.85
EPS Actual-0.010.040.070.030.020.060.080.050.050.060.100.070.060.100.160.150.150.190.260.260.260.340.440.440.400.430.560.560.510.550.640.630.620.640.720.710.640.750.820.820.770.620.730.770.790.720.830.860.870.891.041.020.970.951.071.050.980.941.121.181.231.071.171.181.010.891.061.021.030.841.081.101.081.051.251.281.191.121.341.371.311.331.551.391.401.521.751.681.361.401.731.761.670.941.424.314.483.763.183.963.333.222.362.361.982.042.302.222.152.042.352.302.232.212.622.602.422.503.123.00
Surprise0.00%100.00%16.67%0.00%100.00%100.00%14.29%0.00%25.00%0.00%25.00%0.00%20.00%11.11%0.00%25.00%0.00%18.75%8.33%8.33%8.33%13.33%4.76%4.76%2.56%4.88%1.82%3.70%4.08%3.77%0.00%0.00%1.64%1.59%0.00%0.00%3.23%15.38%7.89%7.89%4.05%-10.14%7.35%1.32%1.28%2.86%6.41%4.88%8.75%8.54%8.33%5.15%1.04%-3.06%0.94%5.00%7.69%-5.05%0.00%6.31%16.04%5.94%0.00%0.00%-4.72%-14.42%-2.75%0.00%10.75%-5.62%1.89%1.85%2.86%0.96%1.63%1.59%0.00%0.00%1.52%1.48%3.15%12.71%9.15%2.21%2.19%1.33%-0.57%0.00%-0.73%1.45%2.98%2.92%4.38%6.82%13.60%15.55%5.66%0.80%11.19%29.41%3.74%7.33%3.96%7.76%4.21%3.55%1.77%1.37%1.90%9.68%0.86%1.77%2.29%2.79%1.95%4.00%2.54%5.49%11.03%5.26%
Timing--Pre-marketPre-marketPre-marketPre-market-------------After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap26.70B
Enterprise Value31.67B
Trailing P/E24.09
Forward P/E19.53
PEG Ratio1.53
Price / Sales2.25
Price / Book3.45
EPS10.04
Book Value69.38
Revenue (TTM)11.84B
Gross Profit (TTM)3.93B
EBITDA2.33B
Profit Margin9.54%
Operating Margin15.43%
Return on Equity15.32%
Return on Assets6.53%
Shares Outstanding110.37M
Shares Float109.44M
Beta0.54
Dividend Yield1.42%
Dividend Rate3.44
Payout Ratio24.78%

Analyst Ratings

Buy
Based on 17 analystsTarget 254.73
  • Strong Buy
    7
  • Buy
    2
  • Hold
    8

Ownership Breakdown

Institutions
98.75%
Insiders
0.43%
Retail / Other
0.82%

Top Institutional Holders

  • BlackRock Inc
    9.28M8.40%
  • Vanguard Capital Management, LLC
    7.23M6.55%
  • Vanguard Portfolio Management, LLC
    6.13M5.55%
  • State Street Corp
    5.52M5.00%
  • T. Rowe Price Associates, Inc.
    5.44M4.93%
  • Boston Partners Global Investors, Inc
    4.74M4.30%
  • JPMorgan Chase & Co
    3.52M3.19%
  • Geode Capital Management, LLC
    3.14M2.84%
  • Morgan Stanley - Brokerage Accounts
    2.46M2.23%
  • EdgePoint Investment
    2.25M2.04%
  • Dimensional Fund Advisors, Inc.
    1.99M1.80%
  • Bank of America Corp
    1.94M1.75%
  • Grantham, Mayo, Van Otterloo & Co., LLC
    1.89M1.71%
  • Wells Fargo & Co
    1.75M1.59%
  • Davis Selected Advisers
    1.56M1.41%
  • Victory Capital Management Inc.
    1.55M1.40%

Top Fund Holders

  • Vanguard MStar Total Stk Mkt Idx Invest
    3.50M3.17%
  • Vanguard 500 Index Investor
    2.90M2.63%
  • Vanguard MStar Mid Cap Index Instl
    2.36M2.14%
  • iShares Core S&P 500 ETF
    1.47M1.33%

Dividends

20264×
0.86Oct 6, 20260.86Jul 8, 20260.86Apr 6, 20260.80Jan 13, 2026
20254×
0.80Oct 3, 20250.80Jul 7, 20250.80Apr 7, 20250.75Jan 14, 2025
20244×
0.75Oct 4, 20240.75Jul 8, 20240.75Apr 5, 20240.71Jan 16, 2024
20234×
0.71Oct 5, 20230.71Jul 10, 20230.71Apr 6, 20230.66Jan 17, 2023
20225×
0.66Oct 3, 20220.66Jul 5, 20220.66Jun 3, 20220.66Apr 5, 20220.62Jan 18, 2022
20213×
0.62Oct 4, 20210.62Jul 6, 20210.62Apr 6, 2021

Stock Splits

  • Jun 21, 20052:1
  • Jun 1, 20012:1